Rémy Cointreau SA (REMYY)
OTCMKTS · Delayed Price · Currency is USD
5.93
+0.02 (0.25%)
Aug 1, 2025, 3:54 PM EDT
Revance Therapeutics Market Cap
Rémy Cointreau has a market cap or net worth of $3.09 billion as of August 1, 2025. Its market cap has decreased by -19.58% in one year.
Market Cap
3.09B
Enterprise Value
3.87B
Revenue
1.06B
Ranking
n/a
PE Ratio
23.57
Stock Price
$5.93
Market Cap Chart
Since May 13, 1993, Rémy Cointreau's market cap has increased from 795.44M to 3.09B, an increase of 288.24%. That is a compound annual growth rate of 4.30%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 3.09B | -1.49% |
Dec 31, 2024 | 3.13B | -51.54% |
Dec 29, 2023 | 6.47B | -23.87% |
Dec 30, 2022 | 8.50B | -31.25% |
Dec 31, 2021 | 12.36B | 32.06% |
Dec 31, 2020 | 9.36B | 52.92% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Cordyceps Sunshine Biotech Holdings | 1.02B |
Cuisine Solutions | 425.59M |
Armanino Foods of Distinction | 260.35M |
South Dakota Soybean Processors, LLC | 203.76M |
Microalliance Group | 194.98M |
ESG Inc. | 154.62M |
Pyxus International | 129.19M |
Crimson Wine Group | 118.16M |